Stephanie L Aungst
4PUBLICATIONS
57CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.Sonia Singh, Diana Bradford, Somak Chatterjee
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Apr 06, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.Katie Chon, Erin Larkins, Somak Chatterjee
Pageof 1
Frequent Collaborators
3 joint publications
Barbara Scepura
3 joint publications
Nicole Drezner
3 joint publications
Claudia P Miller
3 joint publications
Youwei Bi
3 joint publications
Harpreet Singh
3 joint publications
Nam Atiqur Rahman
3 joint publications
Richard Pazdur
2 joint publications
Diana Bradford
2 joint publications
Somak Chatterjee
2 joint publications
Yangbing Li
